SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · A cluster of insider selling at Artiva Biotherapeutics (ARTV) totaling…

Artiva Biotherapeutics, Inc. · CLUSTER filed Sep 9, 2026 at 16:02 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Sep 9, 2026 at 16:02 ET

A cluster of insider selling at Artiva Biotherapeutics (ARTV) totaling $477K over the past week, led by CEO Fred Aslan ($256K open-market sale) and joined by the COO, CTO, and CMO. The selling is modest relative to the $500M market cap (~0.1%), and the cluster is dominated by open-market sales from C-suite executives, which per academic literature are weak predictors of future returns. The net signal is neutral-to-slightly-bearish given the CEO's open-market sale, but the dollar amount is below the materiality threshold for a strong bearish call.

  • CEO Fred Aslan sold 23,429 shares at $10.92 for $256K on Sept 8.
  • COO Jennifer Bush sold 8.4K shares at $11.16 for $94K on Sept 3.
  • CTO Christopher Horan sold 10.4K shares at $11.16 for $116K on Sept 3.
  • CMO Subhashis Banerjee sold 1.1K shares at $11.16 for $12K on Sept 3.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access